Diabetic neuropathy is one of the most common complications of diabetes mellitus. In 50% of cases, the disease proceeds without symptoms. Nonetheless, it can cause severe consequences: digestive disorders, tachycardia, severe arrhythmias, diabetic foot, and diabetic retinopathy. Approximately 30% of patients develop manifestations of neuropathy 20 years after the diagnosis of diabetes mellitus. You can undergo treatment for this disease in Germany. German clinics use modern methods of drug therapy, and some clinics use stem cells to repair the damaged nerves.
Content
- Conservative therapy
- Stem cells
The cost of diabetic neuropathy treatment depends on where you undergo treatment, who carries out your treatment and what methods are used. We will help you select a clinic with the best price ratio and quality of medical services.
It is better to undergo treatment in a clinic whose doctors specialize in therapy for diabetes mellitus and its complications and achieve significant progress: the University Hospital Ulm, the Beta Klinik Bonn, the Charite University Hospital Berlin.
Leave your request with medical information on the Booking Health website. We will recommend the most suitable hospital and healthcare professional, book airline tickets and accommodation, and provide you with interpreting services and medical insurance. Also, a personal medical coordinator will always be in touch with you.
Conservative therapy
The basis of treatment is drug therapy.
Control of diabetes mellitus is necessary to stop the progression of the disease. Doctors use insulin medications and hypoglycemic agents. An insulin pump may be implanted.
One of the main problems of patients is chronic neuropathic pain. It is stopped with painkillers, and many patients also receive antidepressants and anticonvulsants.
The neuropathic form of diabetic foot requires unloading with plaster casts.
Many patients develop vegetative manifestations due to the impaired innervation of organs and tissues. They suffer from the following symptoms: dizziness, tachycardia at rest, orthostatic hypotension (lowering blood pressure after standing upright), stomach discomfort, constipation, diarrhea, fecal incontinence, erectile dysfunction, neurogenic bladder, increased or decreased sweating. In all these situations, symptomatic drug therapy affects certain symptom complexes.
Stem cells
Doctors in Germany use stem cell treatment for retinopathy. It not only relieves symptoms but also provides regression of the disease.
So far, this treatment method is not a standard therapy. Stem cells are harvested from the patient's bone marrow or peripheral blood and then injected intravenously.
Stem cells have the ability of self-renewal and can differentiate into several types of cells, including adipocytes, chondrocytes and osteoblasts, myocytes and neurons. They also produce neurotrophic (improving nerve nutrition) and angiogenic (stimulating the formation of new blood vessels) factors. In total, there are 84 factors that are produced by stem cells, enhancing the regenerative processes in the body.
The main areas of application of stem cells in diabetic polyneuropathy include intractable symptoms, acute exacerbation, diabetic foot with ulcers and critical ischemia of the lower extremities.
Diagnostics and treatment of diabetic neuropathy in Germany demonstrate the best success rates. You are welcome to use the Booking Health website to compare the cost of medical services in different neurological departments of clinics in Germany so that you book the medical program at favorable prices. The Booking Health medical advisors will help you select a hospital and a method of treatment, while travel managers will take care of the arrangement of your trip.
Authors:
The article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova and Dr. Farrukh Ahmed. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Sources:
Centers for Disease Control and Prevention
MedlinePlus
The Lancet
